Predictive testing in non-small cell lung carcinoma | Zendy

Pavel Dundr | Zendy; Radoslav Matěj | Zendy; Kristýěmejcová | Zendy; Michaela Bártů | Zendy; Ivana Stružinská | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predictive testing in non-small cell lung carcinoma

Author(s) -

Pavel Dundr,

Radoslav Matěj,

Kristýěmejcová,

Michaela Bártů,

Ivana Stružinská

Publication year - 2021

Publication title -

klinicka onkologie

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.204

H-Index - 13

eISSN - 1802-5307

pISSN - 0862-495X

DOI - 10.48095/ccko2021s29

Subject(s) - diagnostic test , predictive testing , clinical practice , lung cancer , medicine , process (computing) , computer science , oncology , medical physics , genetic testing , emergency medicine , family medicine , operating system

Predictive testing is a crucial part of the complete diagnostic process of non-small cell lung cancer (NSCLC) and a necessary requirement in order to determine proper course of treatment. However, the possibilities of testing and the spectrum of examined markers are quickly evolving as a result of the progress in diagnostic and therapeutic possibilities, and as such it is necessary to regularly update the current guidelines to achieve proper standards of care in routine practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research